🧬
Biyoteknoloji Sektörü Hisseleri
Biyoteknoloji Sektörü altında 522 Hisse Senedi
Biyoteknoloji sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
Biyoteknoloji Sektörü Hakkında
Biyoteknoloji sektörü, genetik mühendisliği, ilaç geliştirme ve tıbbi araştırma alanında faaliyet gösteren şirketleri kapsar. Yüksek AR-GE yatırımları ve uzun geliştirme süreçleri ile karakterize edilir.
Temel Özellikler
- Yüksek AR-GE yatırımları
- Uzun geliştirme süreçleri
- Düzenleyici onay riskleri
- Yüksek büyüme potansiyeli
Önemli Şirketler
ModernaGilead SciencesBiogenRegeneron
522
Toplam Hisse
$2.5T
Toplam Piyasa Değeri
Biyoteknoloji Sektörü Hisseleri
Sayfa 3/6 (Toplam: 522)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM | |
|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | $313.73M | $6.32 | 2.17% | |
| FULC | Fulcrum Therapeutics, Inc. | $305.52M | $6.88 | 2.76% | |
| TRDA | Entrada Therapeutics, Inc. | $304.77M | $7.60 | 3.80% | |
| HUMA | Humacyte, Inc. | $300.16M | $2.67 | 3.61% | |
| ATYR | aTyr Pharma, Inc. | $294.60M | $4.47 | 5.05% | |
| CRVS | Corvus Pharmaceuticals, Inc. | $294.58M | $3.78 | 0.53% | |
| OLMA | Olema Pharmaceuticals, Inc. | $293.27M | $5.28 | 0.38% | |
| MRVI | Maravai LifeSciences Holdings, Inc. | $287.92M | $2.25 | 5.06% | |
| SMTI | Sanara MedTech Inc. | $286.44M | $29.00 | 1.06% | |
| ITOS | iTeos Therapeutics, Inc. | $285.71M | $10.02 | 0.10% | |
| RZLT | Rezolute, Inc. | $285.03M | $4.12 | 0.84% | |
| STIM | Neuronetics, Inc. | $281.71M | $3.91 | 1.01% | |
| QSI | Quantum-Si incorporated | $281.13M | $1.68 | 1.75% | |
| ABEO | Abeona Therapeutics Inc. | $274.74M | $6.24 | 1.30% | |
| CMPX | Compass Therapeutics, Inc. | $273.80M | $2.10 | 0.94% | |
| HRTX | Heron Therapeutics, Inc. | $266.99M | $1.88 | 1.57% | |
| TSVT | 2seventy bio, Inc. | $266.15M | $5.00 | 0.00% | |
| AURA | Aura Biosciences, Inc. | $264.41M | $5.86 | 3.78% | |
| RNAC | Cartesian Therapeutics, Inc. | $259.41M | $9.56 | 4.40% | |
| CERS | Cerus Corporation | $250.42M | $1.27 | 3.25% | |
| ALLO | Allogene Therapeutics, Inc. | $247.14M | $1.17 | 0.85% | |
| LFCR | Lifecore Biomedical, Inc. | $245.48M | $6.77 | 1.17% | |
| ALMS | Alumis Inc. Common Stock | $242.66M | $3.50 | 10.49% | |
| GLUE | Monte Rosa Therapeutics, Inc. | $242.66M | $4.18 | 1.18% | |
| TERN | Terns Pharmaceuticals, Inc. | $241.93M | $3.11 | 0.32% | |
| GOSS | Gossamer Bio, Inc. | $239.72M | $1.11 | 1.77% | |
| OMER | Omeros Corporation | $238.76M | $3.09 | 6.93% | |
| FHTX | Foghorn Therapeutics Inc. | $236.26M | $4.08 | 5.56% | |
| MXCT | MaxCyte, Inc. | $234.96M | $2.38 | 3.03% | |
| PHAT | Phathom Pharmaceuticals, Inc. | $233.53M | $4.25 | 1.39% | |
| THRD | Third Harmonic Bio, Inc. | $232.41M | $5.21 | 0.00% | |
| PROK | ProKidney Corp. | $228.16M | $0.72 | 0.32% | |
| AQST | Aquestive Therapeutics, Inc. | $227.44M | $2.71 | 2.87% | |
| MNPR | Monopar Therapeutics Inc. | $226.78M | $31.73 | 2.04% | |
| AVIR | Atea Pharmaceuticals, Inc. | $225.07M | $2.97 | 0.68% | |
| DRUG | Bright Minds Biosciences Inc. | $222.77M | $25.95 | 5.12% | |
| NVCT | Nuvectis Pharma, Inc. | $215.55M | $9.41 | 0.64% | |
| NGNE | Neurogene Inc. | $213.93M | $17.01 | 9.23% | |
| CDXS | Codexis, Inc. | $212.08M | $2.30 | 2.13% | |
| NEO | NeoGenomics, Inc. | $207.44M | $7.28 | 1.22% | |
| SLRN | Acelyrin, Inc. | $204.34M | $2.27 | 0.00% | |
| TVGN | Tevogen Bio Holdings Inc. | $203.92M | $1.29 | 3.73% | |
| LXRX | Lexicon Pharmaceuticals, Inc. | $203.45M | $0.63 | 5.03% | |
| KOD | Kodiak Sciences Inc. | $202.61M | $3.40 | 4.76% | |
| OCGN | Ocugen, Inc. | $202.23M | $0.84 | 0.23% | |
| SLDB | Solid Biosciences Inc. | $195.69M | $3.21 | 2.73% | |
| DSGN | Design Therapeutics, Inc. | $195.57M | $3.73 | 6.98% | |
| ANNX | Annexon, Inc. | $192.00M | $2.04 | 6.42% | |
| CATX | Perspective Therapeutics, Inc. | $188.83M | $2.57 | 4.81% | |
| OSUR | OraSure Technologies, Inc. | $188.12M | $2.88 | 1.41% | |
| RCEL | AVITA Medical, Inc. | $181.61M | $5.62 | 2.60% | |
| CRGX | CARGO Therapeutics, Inc. Common Stock | $181.23M | $4.25 | 0.71% | |
| ANIK | Anika Therapeutics, Inc. | $177.98M | $11.15 | 0.98% | |
| INMB | INmune Bio, Inc. | $177.79M | $7.38 | 0.27% | |
| OABI | OmniAb, Inc. | $177.28M | $1.27 | 1.60% | |
| CTMX | CytomX Therapeutics, Inc. | $174.05M | $2.65 | 5.16% | |
| SGHT | Sight Sciences, Inc. | $173.20M | $3.69 | 4.83% | |
| ELDN | Eledon Pharmaceuticals, Inc. | $172.46M | $3.00 | 2.91% | |
| TLSI | TriSalus Life Sciences, Inc. | $163.62M | $5.00 | 8.76% | |
| QTRX | Quanterix Corporation | $163.08M | $5.20 | 0.67% | |
| TNXP | Tonix Pharmaceuticals Holding Corp. | $161.87M | $39.78 | 5.33% | |
| PRME | Prime Medicine, Inc. | $161.49M | $1.18 | 6.35% | |
| INBX | Inhibrx Biosciences, Inc. | $161.41M | $13.47 | 2.04% | |
| IZTC | Invizyne Technologies Inc. Common Stock | $157.23M | $16.50 | 6.45% | |
| DERM | Journey Medical Corporation | $154.45M | $8.06 | 0.12% | |
| ESPR | Esperion Therapeutics, Inc. | $146.09M | $0.85 | 2.39% | |
| FDMT | 4D Molecular Therapeutics, Inc. | $145.69M | $3.62 | 2.43% | |
| PBYI | Puma Biotechnology, Inc. | $144.20M | $3.28 | 2.96% | |
| SLS | SELLAS Life Sciences Group, Inc. | $144.19M | $1.71 | 0.00% | |
| BIOA | BioAge Labs, Inc. | $143.04M | $3.96 | 0.50% | |
| CVRX | CVRx, Inc. | $140.01M | $6.63 | 2.43% | |
| KRRO | Korro Bio, Inc. | $139.64M | $11.42 | 2.64% | |
| TNGX | Tango Therapeutics, Inc. | $139.29M | $2.22 | 4.72% | |
| NKTX | Nkarta, Inc. | $134.82M | $1.74 | 3.87% | |
| NKTR | Nektar Therapeutics | $133.29M | $0.72 | 2.02% | |
| ACRS | Aclaris Therapeutics, Inc. | $132.10M | $1.46 | 0.00% | |
| RPID | Rapid Micro Biosystems, Inc. | $131.92M | $3.33 | 1.19% | |
| SEER | Seer, Inc. | $127.63M | $1.92 | 0.52% | |
| GLSI | Greenwich LifeSciences, Inc. | $127.43M | $9.85 | 0.71% | |
| LUCD | Lucid Diagnostics Inc. | $126.46M | $1.39 | 8.55% | |
| ALDX | Aldeyra Therapeutics, Inc. | $124.58M | $2.15 | 5.70% | |
| TARA | Protara Therapeutics, Inc. | $120.95M | $3.04 | 2.88% | |
| LYEL | Lyell Immunopharma, Inc. | $120.82M | $0.44 | 8.74% | |
| EDIT | Editas Medicine, Inc. | $118.45M | $1.72 | 6.01% | |
| SCPH | scPharmaceuticals Inc. | $116.91M | $3.64 | 2.54% | |
| ATOS | Atossa Therapeutics, Inc. | $114.96M | $0.78 | 2.18% | |
| LRMR | Larimar Therapeutics, Inc. | $113.33M | $2.25 | 2.17% | |
| FATE | Fate Therapeutics, Inc. | $112.85M | $1.21 | 8.33% | |
| OBIO | Orchestra BioMed Holdings, Inc. | $112.26M | $2.85 | 0.71% | |
| ENTA | Enanta Pharmaceuticals, Inc. | $111.36M | $5.93 | 3.73% | |
| ALEC | Alector, Inc. | $110.99M | $1.33 | 6.34% | |
| LCTX | Lineage Cell Therapeutics, Inc. | $107.97M | $0.66 | 3.10% | |
| NAUT | Nautilus Biotechnology, Inc. | $106.69M | $0.75 | 6.58% | |
| CCCC | C4 Therapeutics, Inc. | $106.51M | $1.25 | 5.30% | |
| SGMO | Sangamo Therapeutics, Inc. | $105.51M | $0.47 | 1.59% | |
| IRWD | Ironwood Pharmaceuticals, Inc. | $104.67M | $0.60 | 5.13% | |
| IVVD | Invivyd, Inc. | $101.97M | $0.94 | 10.29% | |
| NMRA | Neumora Therapeutics, Inc. Common Stock | $99.88M | $0.72 | 0.33% | |
| COYA | Coya Therapeutics, Inc. | $99.56M | $5.33 | 0.03% | |
| RAPT | RAPT Therapeutics, Inc. | $99.23M | $0.89 | 4.84% |